Evommune, Inc. · NYSE:EVMN
Pena Luis C. received 1,115 Evommune, Inc. shares as an award (Form 4)
Traded Sep 30, 2026 · Filed Oct 15, 2026
On Sep 30, 2026, Pena Luis C. (Director, President & CEO) received 1,115 Evommune, Inc. shares as an award at US$7.02 for US$7,827, leaving 631,573 shares. Filed Oct 15, 2026 (Form 4).
- Awarded
- 1,115 shares
- Price
- US$7.02
- Value
- US$7,827
- Holding after
- 631,573 shares
- Trading plan
- No
- Role
- Director, President & CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 30, 2026 | Common Stock | Award | 1,115 | US$7.02 | 631,573 | Direct |
Source
Download original · View original at SEC
Related
- Evommune, Inc.
- Pena Luis C.
- Evommune, Inc. shareholders
- Form 4 · Pena Luis C. · Jun 24, 2026
- Form 4 · Pena Luis C. · Jun 3, 2026
- Schedule 13G · T. Rowe Price Associates Inc · Aug 14, 2026
- Schedule 13G/A · Andera Partners · Aug 14, 2026
- Schedule 13G · Point72 Asset Management, L.P. · Jul 16, 2026
- Form 4 · Carver Kyle · Jul 10, 2026
- Form 4 · Kirsch Arthur S · Jul 8, 2026